Meet the Neuro-Oncology Faculty

Neuro-oncology in the Hermelin Brain Tumor Center (HBTC) at Henry Ford Health has a longstanding history as a national leader for brain tumor research, clinical care, and innovation recognized by the National Cancer Institute (NCI) since 1993. Our neuro-oncology team is well known for expertise in early phase clinical trials, comprehensive multidisciplinary care, and translational research. HBTC is the only site in Michigan to participate in the Adult Brain Tumor Consortium and Brain Tumor Trials Collaborative, as well as other clinical trial and research consortiums that allow us to deliver the highest level of brain tumor care possible. The HBTC is a place for hope with a dedicated team of clinicians, researchers, and support services that care for all aspects of our patients. We are committed to creating a brighter future for those impacted by neuro-oncologic conditions through research and by educating the next generation of neuro-oncologist, neurologist, and care providers.